Improved success of living unrelated renal transplantation with cyclosporine immunosuppression

J Urol. 1993 Apr;149(4):706-8. doi: 10.1016/s0022-5347(17)36188-8.

Abstract

Kidney transplantation with a living unrelated donor was performed in 13 patients. The donors comprised 10 spouses, 2 brothers-in-law and 1 stranger. All donor-recipient pairs were red blood cell compatible with a negative T cell crossmatch. Five patients underwent transplantation before 1984 without cyclosporine immunosuppression; the 1-year patient and graft survival rates in this group were 40% and 20%, respectively. Eight patients have undergone transplantation since 1985 with cyclosporine immunosuppression. The 1-year patient and graft survival rates in this group were 100% and 88%, respectively (p = 0.03). Currently, 6 patients in the latter group have a well functioning graft with serum creatinine levels of 1.2 to 2.0 mg./dl. (mean 1.5 mg./dl.) and with followup of 1 to 6 years (mean 2.9 years). Excellent graft survival results can now be achieved with living unrelated donors and their expanded use can provide an important additional source of organs for transplantation.

MeSH terms

  • Cyclosporine / therapeutic use*
  • Female
  • Graft Rejection / drug therapy
  • Graft Survival / immunology*
  • Histocompatibility Testing
  • Humans
  • Immunosuppression Therapy / methods*
  • Kidney Transplantation / immunology*
  • Kidney Transplantation / mortality
  • Male
  • Middle Aged
  • Tissue Donors*
  • Treatment Outcome

Substances

  • Cyclosporine